Goodwin Procter advised Qilu Pharmaceutical on the deal. Qilu Pharmaceutical, one of the leading pharmaceutical companies in China (“Qilu”), announced its exclusive licensing agreement and strategic partnership...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here